<DOC>
	<DOCNO>NCT01541735</DOCNO>
	<brief_summary>The purpose study evaluate effect pantoprazole insulin secretion drug-naïve patient type 2 diabetes .</brief_summary>
	<brief_title>Pantoprazole Insulin Secretion Diabetes</brief_title>
	<detailed_description>Type 2 diabetes mellitus ( T2DM ) become major health problem worldwide high prevalence relate mortality , high rate disability economically active . In Mexico prevalence 14.4 % report one high Latin America estimate cost $ 778 million allocate disease 2010 , i.e. , tenth place worldwide . Within pathophysiology alteration secretion insulin action , qualitatively quantitatively , implies challenge long-term metabolic control pharmacological arsenal available today . Since function pancreatic β cell decrease function time lack control essential metabolic find drug preserve pancreatic cell mass even promote neogenesis , aim restore physiological secretion insulin lose early stage type 2 diabetes achieve optimal glycemic control sustain time avoid complication reduce cost associated disease . Have evaluate animal model promise result Proton Pumps Inhibitors ( PPI ) restoration glucose preservation pancreatic cell function , include promote growth increase level gastrin , appear act growth factor . However , present mechanism evaluate human , would interest assess effect administration PPI pantoprazole , phase insulin secretion patient T2DM recent diagnosis . Material Methods : Randomized , double-blind , placebo control clinical trial . Population : 14 drug-naive adult patient T2DM obesity . Hyperglycemic-hyperinsulinemic clamp ass phase insulin secretion . Intervention 45 day : pantoprazole 40mg placebo .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Type 2 diabetes mellitus DrugNaive No complication HbA1c 7 &lt; 9 % Fasting plasma glucose &lt; 210mg/dl Body mass index 30.0 39.9 body weight stable least 3 month study Non smoker Blood pressure &lt; 130/80 Diabetes complication Women pregnant stage lactation Hepatic , renal , autoimmune disease Take drug effect insulin secretion ZollingerEllison disease Gastric pancreatic tumor .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Insulin</keyword>
	<keyword>Pantoprazole</keyword>
</DOC>